(Q36584801)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852412%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

title

Systemic weakness after therapeutic injections of botulinum toxin a: a case series and review of the literature (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852412%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

author

Diego R Torres-Russotto

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852412%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

author name string

Beth E Crowner

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852412%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Alexandre R Carter

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852412%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Brad A Racette

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852412%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

publication date

1 September 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852412%20AND%20SRC:MED&resulttype=core&format=json

Clinical Neuropharmacology

14 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852412%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852412%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852412%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

page(s)

243-247

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852412%20AND%20SRC:MED&resulttype=core&format=json

Safety of botulinum toxin type A among children with spasticity secondary to cerebral palsy: a systematic review of randomized clinical trials

14 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3563356

High dose botulinum toxin A for the treatment of lower extremity hypertonicity in children with cerebral palsy.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3563356

Complications of botulinum toxin type A.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3563356

Safety of high-dose botulinum toxin type A therapy for the treatment of pediatric spasticity

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3563356

Use of botulinum toxin in pediatric spasticity (cerebral palsy).

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3563356

Use of botulinum toxin type A in pediatric patients with cerebral palsy: a three-center retrospective chart review

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3563356

Generalised muscular weakness after botulinum toxin injections for dystonia: a report of three cases

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3563356

A double blind, randomised, parallel group study to investigate the dose equivalence of Dysport and Botox in the treatment of cervical dystonia

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3563356

Generalised botulism-like syndrome after intramuscular injections of botulinum toxin type A: a report of two cases

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3563356

Botulinum toxin therapy: distant effects on neuromuscular transmission and autonomic nervous system.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3563356

Systemic toxicity of botulinum toxin by intramuscular injection in the monkey

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3563356

Contralateral weakness and fatigue after high-dose botulinum toxin injection for management of poststroke spasticity

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3563356

Iatrogenic botulism in an amateur weight-lifter

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3563356

Botulinum toxin type a neuromuscular blockade in the treatment of equinus foot deformity in cerebral palsy: a multicenter, open-label clinical trial.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3563356

Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: a randomized, double-blind, placebo-controlled trial. BOTOX Study Group

20 September 2018

1 reference

12 December 2020

Safety profile and efficacy of botulinum toxin A (Dysport) in children with muscle spasticity

1 reference

12 December 2020

Muscular weakness as side effect of botulinum toxin injection for neurogenic detrusor overactivity

1 reference

12 December 2020

Botulinum toxin for blepharospasm: single-fiber EMG studies

1 reference

12 December 2020

Distant effects of local injection of botulinum toxin

1 reference

12 December 2020

Time course of distant effects of local injections of botulinum toxin

1 reference

12 December 2020

Management of spasticity in cerebral palsy with botulinum-A toxin: report of a preliminary, randomized, double-blind trial

1 reference

12 December 2020

Idiosyncratic adverse reactions to intramuscular botulinum toxin type A injection

1 reference

12 December 2020

Botulinum toxin: chemistry, pharmacology, toxicity, and immunology

1 reference

12 December 2020

Cerebral palsy: a rational approach to a treatment protocol, and the role of botulinum toxin in treatment

1 reference

12 December 2020

Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia

1 reference

12 December 2020

When it comes to botulinum toxin, children and adults are not the same: multimuscle option for children with cerebral palsy

1 reference

12 December 2020

Botulinum neurotoxin A: an unusual systemic effect

1 reference

12 December 2020

10.1097/WNF.0B013E3181F5329E

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852412%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852412%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

PubMed publication ID

20852412

1 reference